Kay Yeung, MD, PhD

Kay Yeung

Dr. Yeung is a recent graduate of New York University School of Medicine. She received her undergraduate degree from Binghamton University in 2002, where she studied biochemistry.

She is a third-year fellow in hematology-oncology.

Selected Publications

Yeung K, Yang J. Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol. 2017 Jan; 11(1):28-39. PMID: 28085222.

Yeung K, Cohen EE. Lenvatinib in Advanced, Radioactive Iodine-Refractory, Differentiated Thyroid Carcinoma. Clin Cancer Res. 2015 Dec 15; 21(24):5420-6. PMID: 26487760.

Das S, Yeung K, Mahajan MA, Samuels HH. Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain. BMC Cancer. 2014; 14(1):852. PMID: 25409762.

Yeung K, Das S, Zhang J, Lomniczi A, Ojeda SR, Xu CF, Neubert TA, Samuels HH. A novel transcription complex that selectively modulates apoptosis of breast cancer cells through regulation of FASTKD2. Mol Cell Biol. 2011 Jun; 31(11):2287-98. PMID: 21444724.

Tinnikov AA, Yeung K, Das S, Samuels HH. Identification of a novel pathway that selectively modulates apoptosis of breast cancer cells. Cancer Res. 2009 Feb 15; 69(4):1375-82. PMID: 19190336.

Yasmin R, Yeung K, Chung RH, Gaczynska ME, Osmulski PA, Noy N. DNA-looping by RXR tetramers permits transcriptional regulation "at a distance". J Mol Biol. 2004 Oct 15; 343(2):327-38. PMID: 15451664.